|
|
Volumn 111, Issue 1, 2001, Pages 71-72
|
|
A new era in type 2 diabetes mellitus treatment?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACARBOSE;
ALPHA GLUCOSIDASE INHIBITOR;
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
GLIPIZIDE;
GLUCOSE;
GLYCOSYLATED HEMOGLOBIN;
HIGH DENSITY LIPOPROTEIN;
INSULIN;
METFORMIN;
MIGLITOL;
ORAL ANTIDIABETIC AGENT;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PHENFORMIN;
PIOGLITAZONE;
REPAGLINIDE;
ROSIGLITAZONE;
SULFONYLUREA DERIVATIVE;
THIOZOLIDINEDIONE DERIVATIVE;
TOLBUTAMIDE;
TRIACYLGLYCEROL;
TROGLITAZONE;
UNCLASSIFIED DRUG;
ADJUVANT CHEMOTHERAPY;
CARDIOVASCULAR DISEASE;
DIABETIC OBESITY;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG FATALITY;
DRUG MECHANISM;
DRUG RESPONSE;
DRUG TOLERABILITY;
DRUG USE;
EDITORIAL;
HUMAN;
HYPERGLYCEMIA;
INSULIN BLOOD LEVEL;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
KIDNEY FAILURE;
LIVER FAILURE;
LIVER TOXICITY;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
TREATMENT OUTCOME;
ACARBOSE;
CARBAMATES;
DIABETES MELLITUS, TYPE 2;
GLUCOSAMINE;
HUMANS;
HYPOGLYCEMIC AGENTS;
IMINO PYRANOSES;
MULTICENTER STUDIES;
PIPERIDINES;
RANDOMIZED CONTROLLED TRIALS;
THIAZOLES;
THIAZOLIDINEDIONES;
|
|
EID: 0034938809
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(01)00743-4 Document Type: Editorial |
|
Times cited : (7)
|
|
References (12)
|
